Tel : 301-363-4651 Professional and Accurate! We are your good partner in biology research.



Mouse anti-abscisic acid monoclonal antibody expected to reduce cost


View:319 Time:2013-03-07


The scientists have been hoping to crack the drugs Mouse anti-abscisic acid monoclonal antibody technology.

According to reports, Streptonigrin antitumor antibiotic produced by Streptomyces by a fluff it has a broad-spectrum anti-tumor activity, especially for malignant lymphoma, chronic lymphocytic leukemia and chronic myelogenous leukemia have better clinicalefficacy. Drug seventies and eighties in the last century, has been called the anti-cancer medicine used in the clinical trials, but ultimately not been widely used in clinical practice.

In this Mouse anti- abscisic acid monoclonal antibody process, also discloses a plurality of novel or key molecular biological mechanism of enzyme catalyzed reactions. The study antibiotics novel enzyme-catalyzed reaction gene mining, and laid the basis for the work to create a new structure derivatives using synthetic biology and other cutting-edge biotechnology.

The price of new drugs in the future, but also the focus of the research team. The streptonigrin standard price is very expensive, and 1 mg of the compound of about 900 yuan, 4000 yuan and its analogs. The price of ordinary families, it is a great burden.

Reducing the cost of Mouse anti- abscisic acid monoclonal antibody is necessary, on the need to increase production now, the researchers of the research results can be up to about 200 mg / liter of fermentation broth. This production is several times higher than the original producing bacteria, so the cost is expected to reduce.

 
About news

Newsletters

Get all the lasted information on Events, Sales and Offers. Sign up for newsletter today.

Copyright © 2007-2015 www.cusabio.com Cusabio Biotech Co., Ltd All Rights Reserved.

Wait!

Join the 25,000 subscribers to get research hotpots, technical tips, latest information on events, sales and offers.

Sign up now!

We don't deal in spam.